Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK PHARMA vs TORRENT PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GLENMARK PHARMA TORRENT PHARMA GLENMARK PHARMA/
TORRENT PHARMA
 
P/E (TTM) x -31.4 58.9 - View Chart
P/BV x 2.9 14.2 20.1% View Chart
Dividend Yield % 0.3 0.8 30.9%  

Financials

 GLENMARK PHARMA   TORRENT PHARMA
EQUITY SHARE DATA
    GLENMARK PHARMA
Mar-23
TORRENT PHARMA
Mar-23
GLENMARK PHARMA/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs4871,723 28.3%   
Low Rs3491,243 28.1%   
Sales per share (Unadj.) Rs460.4284.2 162.0%  
Earnings per share (Unadj.) Rs13.436.8 36.4%  
Cash flow per share (Unadj.) Rs35.057.7 60.8%  
Dividends per share (Unadj.) Rs2.5022.00 11.4%  
Avg Dividend yield %0.61.5 40.3%  
Book value per share (Unadj.) Rs335.1183.1 183.0%  
Shares outstanding (eoy) m282.17338.45 83.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.95.2 17.4%   
Avg P/E ratio x31.340.3 77.6%  
P/CF ratio (eoy) x11.925.7 46.4%  
Price / Book Value ratio x1.28.1 15.4%  
Dividend payout %18.759.8 31.3%   
Avg Mkt Cap Rs m117,953501,779 23.5%   
No. of employees `000NANA-   
Total wages/salary Rs m27,81016,777 165.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m129,90196,202 135.0%  
Other income Rs m3,168632 501.1%   
Total revenues Rs m133,06996,834 137.4%   
Gross profit Rs m15,12528,240 53.6%  
Depreciation Rs m6,1137,066 86.5%   
Interest Rs m3,4963,334 104.8%   
Profit before tax Rs m8,68518,472 47.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4,9116,019 81.6%   
Profit after tax Rs m3,77412,452 30.3%  
Gross profit margin %11.629.4 39.7%  
Effective tax rate %56.532.6 173.5%   
Net profit margin %2.912.9 22.4%  
BALANCE SHEET DATA
Current assets Rs m98,73753,137 185.8%   
Current liabilities Rs m50,45554,473 92.6%   
Net working cap to sales %37.2-1.4 -2,676.8%  
Current ratio x2.01.0 200.6%  
Inventory Days Days715 43.2%  
Debtors Days Days1157 1,561.5%  
Net fixed assets Rs m76,92091,390 84.2%   
Share capital Rs m2821,692 16.7%   
"Free" reserves Rs m94,28160,288 156.4%   
Net worth Rs m94,56361,981 152.6%   
Long term debt Rs m38,52124,962 154.3%   
Total assets Rs m175,658144,682 121.4%  
Interest coverage x3.56.5 53.3%   
Debt to equity ratio x0.40.4 101.1%  
Sales to assets ratio x0.70.7 111.2%   
Return on assets %4.110.9 37.9%  
Return on equity %4.020.1 19.9%  
Return on capital %9.225.1 36.5%  
Exports to sales %021.8 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA20,994 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m46,46420,994 221.3%   
Fx outflow Rs m12,7123,735 340.3%   
Net fx Rs m33,75117,259 195.6%   
CASH FLOW
From Operations Rs m6,25423,681 26.4%  
From Investments Rs m-5,285-24,153 21.9%  
From Financial Activity Rs m-775774 -100.1%  
Net Cashflow Rs m3251,101 29.5%  

Share Holding

Indian Promoters % 46.7 71.3 65.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 34.7 21.3 162.8%  
FIIs % 23.7 14.1 168.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.4 28.8 185.6%  
Shareholders   209,931 69,117 303.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GLENMARK PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Glenmark Pharma vs Torrent Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Glenmark Pharma vs Torrent Pharma Share Price Performance

Period Glenmark Pharma Torrent Pharma S&P BSE HEALTHCARE
1-Day -0.57% 1.45% 1.18%
1-Month 5.16% -0.30% -0.75%
1-Year 112.94% 68.52% 61.82%
3-Year CAGR 27.51% 27.16% 18.16%
5-Year CAGR 8.05% 21.87% 19.79%

* Compound Annual Growth Rate

Here are more details on the Glenmark Pharma share price and the Torrent Pharma share price.

Moving on to shareholding structures...

The promoters of Glenmark Pharma hold a 46.7% stake in the company. In case of Torrent Pharma the stake stands at 71.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Glenmark Pharma and the shareholding pattern of Torrent Pharma.

Finally, a word on dividends...

In the most recent financial year, Glenmark Pharma paid a dividend of Rs 2.5 per share. This amounted to a Dividend Payout ratio of 18.7%.

Torrent Pharma paid Rs 22.0, and its dividend payout ratio stood at 59.8%.

You may visit here to review the dividend history of Glenmark Pharma, and the dividend history of Torrent Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.